4
Changes in Ownership
Syndax Pharmaceuticals Inc Filed Acc 0001562180-17-002004
Options or other derivatives
- Director acquired 15,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Chen Henry · Director
Table II: Derivative
2 lines| Date | Transaction | Shares | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| 2017-05-17 | Grant or award : show line 1 in the form Stock Option (Right to Buy) | +10,000 | $13.58 | 2027-05-17 | 10,000 | 10,000 | D |
| 2017-05-17 | Grant or award : show line 2 in the form Stock Option (Right to Buy) | +5,000 | $13.58 | 2027-05-17 | 5,000 | 5,000 | D |
Loading xslF345X03/primarydocument.xml…